115 results
424B3
PASG
Passage Bio Inc
14 May 24
Prospectus supplement
8:15am
, a leader in the genetic medicines field. Our research collaboration with GTP provides us with access to one of the premier research institutions … to certain limitations. We also have access to platform technologies related to development of novel capsids, toxicity reduction technologies
S-3
PASG
Passage Bio Inc
4 Mar 24
Shelf registration
4:09pm
research collaboration with GTP provides us with access to one of the premier research institutions in the world for the discovery and preclinical … for certain rare monogenic and certain non-rare, non-monogenic, or large, CNS disorders, subject to certain limitations. We also have access to platform
8-K
EX-99.1
l8z65xvf u4
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
EX-99.2
k32dou bsrthkxw
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
EX-99.1
gklsf10cfg6gsbe7
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
EX-99.2
xkiwnecb212ypm
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
EX-99.2
kj8ruy2
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
8-K
EX-99.1
re4o3
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
PRE 14A
5yxhwha
3 Apr 23
Preliminary proxy
4:05pm